Sachana, M., Rolaki, A., & Bal-Price, A. (2018). Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children. Toxicol Appl Pharmacol.
Dyfyniad Arddull ChicagoSachana, Magdalini, Alexandra Rolaki, and Anna Bal-Price. "Development of the Adverse Outcome Pathway (AOP): Chronic Binding of Antagonist to N-methyl-d-aspartate Receptors (NMDARs) During Brain Development Induces Impairment of Learning and Memory Abilities of Children." Toxicol Appl Pharmacol 2018.
Dyfyniad MLASachana, Magdalini, Alexandra Rolaki, and Anna Bal-Price. "Development of the Adverse Outcome Pathway (AOP): Chronic Binding of Antagonist to N-methyl-d-aspartate Receptors (NMDARs) During Brain Development Induces Impairment of Learning and Memory Abilities of Children." Toxicol Appl Pharmacol 2018.